Founders Capital Management (Texas)’s VolitionRx Ltd VNRX Stock Holding History

Founders Capital Management (Texas)’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-100	Closed	-$1.36K	–	426
2025 Q3	$1.36K	Hold	100	–	–	﹤0.01%	359
2025 Q2	$1.52K	Hold	100	–	–	﹤0.01%	350
2025 Q1	$1.14K	Hold	100	–	–	﹤0.01%	339
2024 Q4	$1.2K	Hold	100	–	–	﹤0.01%	333
2024 Q3	$1.2K	Hold	100	–	–	﹤0.01%	342
2024 Q2	$1.21K	Hold	100	–	–	﹤0.01%	343
2024 Q1	$1.51K	Hold	100	–	–	﹤0.01%	332
2023 Q4	$1.43K	Sell	100 -100	-50%	-$1.47K	﹤0.01%	358
2023 Q3	$2.76K	Hold	200	–	–	﹤0.01%	360
2023 Q2	$5.56K	Hold	200	–	–	﹤0.01%	339
2023 Q1	$8K	Hold	200	–	–	0.01%	332
2022 Q4	$10K	Hold	200	–	–	0.01%	304
2022 Q3	$5K	Hold	200	–	–	﹤0.01%	345
2022 Q2	$8K	Buy	200 +50	+33%	+$2.52K	0.01%	345
2022 Q1	$9K	Hold	150	–	–	0.01%	276
2021 Q4	$9K	Hold	150	–	–	0.01%	276
2021 Q3	$9K	Hold	150	–	–	0.01%	280
2021 Q2	$10K	Buy	+150	New	+$10.2K	0.01%	266

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Founders Capital Management (Texas)'s VNRX Position: Q4 2025 in Review

Founders Capital Management (Texas) sold out of VolitionRx Ltd (VNRX) in Q4 2025, closing a stake of 100 shares — an estimated $1.36K sold.

Founders Capital Management (Texas) first reported a position in VNRX in Q2 2021 and held it in 18 quarters. The position peaked at $10K in Q4 2022. 28 funds tracked by Wall St. Rank hold VNRX as of Q4 2025.

Founders Capital Management (Texas) reported no remaining VolitionRx Ltd position as of Q4 2025 after selling out during the quarter.
Founders Capital Management (Texas) sold 100 VolitionRx Ltd shares in Q4 2025, an estimated $1.36K.
Founders Capital Management (Texas) first reported a position in VolitionRx Ltd in Q2 2021 and held it in 18 quarters.
Founders Capital Management (Texas)'s VolitionRx Ltd position peaked at $10K in Q4 2022.
28 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2025.

Based on Founders Capital Management (Texas)'s 13F filing for Q4 2025, filed 15 Jan 2026.